Diana L. Price
Diana L. Price
Other namesDiana L. Martinez-Price, Diana L. Martinez
Neuropore Therapies
Verified email at
Cited by
Cited by
Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury
U Wilhelmsson, EA Bushong, DL Price, BL Smarr, V Phung, M Terada, ...
Proceedings of the National Academy of Sciences 103 (46), 17513-17518, 2006
A de novo compound targeting α-synuclein improves deficits in models of Parkinson’s disease
W Wrasidlo, IF Tsigelny, DL Price, G Dutta, E Rockenstein, TC Schwarz, ...
Brain 139 (12), 3217-3236, 2016
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease
DL Price, MA Koike, A Khan, W Wrasidlo, E Rockenstein, E Masliah, ...
Scientific reports 8 (1), 16165, 2018
Distribution of rSlo Ca2+-activated K+ channels in rat astrocyte perivascular endfeet
DL Price, JW Ludwig, H Mi, TL Schwarz, MH Ellisman
Brain research 956 (2), 183-193, 2002
The cell-centered database: a database for multiscale structural and protein localization data from light and electron microscopy
ME Martone, S Zhang, A Gupta, X Qian, H He, DL Price, M Wong, ...
Neuroinformatics 1, 379-395, 2003
Automated microscopy system for mosaic acquisition and processing
SK Chow, H Hakozaki, DL Price, NAB MacLean, TJ Deerinck, JC Bouwer, ...
Journal of microscopy 222 (2), 76-84, 2006
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy–implications for excitotoxicity
DL Price, E Rockenstein, K Ubhi, V Phung, N MacLean-Lewis, D Askay, ...
PloS one 5 (11), e14020, 2010
Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5–implications for dementia with Lewy bodies
CR Overk, A Cartier, G Shaked, E Rockenstein, K Ubhi, B Spencer, ...
Molecular neurodegeneration 9, 1-18, 2014
Characterization of the disruptions of prepulse inhibition and habituation of startle induced by α-ethyltryptamine
DL Martinez, MA Geyer
Neuropsychopharmacology 16 (3), 246-255, 1997
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease
K McFarland, DL Price, DW Bonhaus
Behavioural pharmacology 22 (7), 681-692, 2011
Longitudinal live imaging of retinal α-synuclein:: GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
DL Price, E Rockenstein, M Mante, A Adame, C Overk, B Spencer, ...
Scientific reports 6 (1), 29523, 2016
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer’s disease
DL Price, DW Bonhaus, K McFarland
Behavioural Pharmacology 23 (4), 426-433, 2012
Collaborative development of the Arrowsmith two node search interface designed for laboratory investigators
NR Smalheiser, VI Torvik, A Bischoff-Grethe, LB Burhans, M Gabriel, ...
Journal of biomedical discovery and collaboration 1 (1), 1-18, 2006
AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson’s disease rat model
K McFarland, DL Price, CN Davis, JN Ma, DW Bonhaus, ES Burstein, ...
ACS chemical neuroscience 4 (9), 1249-1255, 2013
High-resolution large-scale mosaic imaging using multiphoton microscopy to characterize transgenic mouse models of human neurological disorders
DL Price, SK Chow, NAB MacLean, H Hakozaki, S Peltier, ME Martone, ...
Neuroinformatics 4, 65-80, 2006
Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons
ML Berlanga, DL Price, BS Phung, R Giuly, M Terada, N Yamada, M Cyr, ...
Brain research 1390, 41-49, 2011
Neuroprotective effects of the anti‐cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders
W Wrasidlo, LA Crews, IF Tsigelny, E Stocking, VL Kouznetsova, D Price, ...
British journal of pharmacology 171 (24), 5757-5773, 2014
Subthalamic 5-HT1A and 5-HT1B receptor modulation of RU 24969-induced behavioral profile in rats
DL Martinez-Price, MA Geyer
Pharmacology Biochemistry and Behavior 71 (4), 569-580, 2002
Behavioral psychopharmacology of MDMA and MDMA-like drugs: A review of human and animal studies
D Martinez-Price, K Krebs-Thomson, M Geyer
Addiction Research & Theory 10 (1), 43-67, 2002
NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson’s disease
A Khan, R Johnson, C Wittmer, M Maile, K Tatsukawa, JL Wong, MB Gill, ...
Brain 144 (12), 3692-3709, 2021
The system can't perform the operation now. Try again later.
Articles 1–20